Zhou Bing-Bo, Hui Ling, Zhang Qing-Hua, Chen Xue, Zhang Chuan, Zheng Lei, Feng Xuan, Wang Yu-Pei, Ding Zhong-Jun, Chen Rui-Rong, Ma Pan-Pan, Liu Fu-Rong, Hao Sheng-Ju
The Center for Medical Genetics in Gansu Provincial Maternity and Child-care Hospital, Gansu Provincial Clinical Research Center for Birth Defects and Rare Diseases, Lanzhou, China.
The Center for Reproductive Medicine in Gansu Provincial Maternity and Child-care Hospital, Lanzhou, China.
Front Genet. 2022 May 12;13:854712. doi: 10.3389/fgene.2022.854712. eCollection 2022.
Nonketotic hyperglycinemia is a metabolic disease with autosomal recessive inheritance due to the glycine cleavage system (GCS) defect leading to the accumulation of glycine that causes severe and fatal neurological symptoms in the neonatal period. Genomic DNA was extracted from the peripheral blood of the female proband and her family members. The variation was detected in the patient by whole-exome sequencing (WES), and the variant was validated by Sanger sequencing. The WES showed that there were novel compound heterozygous frameshift variations c.977delA (p.Glu326Glyfs12) and c.982_983insG (p.Ala328Glyfs22) in exon eight of the gene (NM_000481.4) in the proband. Genetic analysis showed that the former was inherited from the mother, and the latter was inherited from the father. We report the novel compound heterozygous variation of the gene in a Chinese girl with NKH by WES, which has never been reported previously. Our case expanded the gene mutation spectrum, further strengthened the understanding of NKH, and deepened the genetic and clinical heterogeneity of the disease. However, the study of treatment and prognosis is still our future challenge and focus.
非酮症高甘氨酸血症是一种常染色体隐性遗传的代谢性疾病,由于甘氨酸裂解系统(GCS)缺陷导致甘氨酸蓄积,在新生儿期引起严重且致命的神经症状。从女性先证者及其家庭成员的外周血中提取基因组DNA。通过全外显子组测序(WES)在患者中检测到变异,并通过桑格测序对该变异进行验证。WES显示,先证者该基因(NM_000481.4)第八外显子存在新的复合杂合移码变异c.977delA(p.Glu326Glyfs12)和c.982_983insG(p.Ala328Glyfs22)。遗传分析表明,前者遗传自母亲,后者遗传自父亲。我们通过WES报告了一名患有非酮症高甘氨酸血症的中国女孩该基因新的复合杂合变异,此前从未有过相关报道。我们的病例扩展了该基因突变谱,进一步加强了对非酮症高甘氨酸血症的认识,并加深了该疾病的遗传和临床异质性。然而,治疗和预后的研究仍是我们未来面临的挑战和重点。